Treatment of coronary bifurcation lesions with the Absorb bioresorbable vascular scaffold in combination with the Tryton dedicated coronary bifurcation stent: evaluation using two- and three-dimensional optical coherence tomography.
The Tryton bifurcation stent has been developed to improve clinical outcomes after treatment of bifurcation lesions. Limited data are available on the use of the Absorb bioresorbable vascular scaffold (BVS) in bifurcation lesions with side branches >2 mm. We present here the acute procedural results and midterm clinical follow-up of the first-in-man combined use of the Tryton stent and the Absorb scaffold for the treatment of complex bifurcation lesions. Ten patients treated with the Tryton stent in combination with Absorb BVS were included in the current report. Offline two- and three-dimensional optical coherence tomography (OCT) analyses were performed to gain more insights into this novel approach. Procedural success was 91%, whereas angiographic success was achieved in 82%. Two TLRs occurred (TLR rate 20%), whereas no deaths, myocardial infarctions or stent thromboses were observed up to six months of follow-up. We present a new treatment strategy in complex bifurcation lesions using the Tryton stent in combination with the Absorb BVS. This approach potentially offers an opportunity to treat complex bifurcation lesions with the Absorb BVS. Furthermore, three-dimensional OCT reconstructions give valuable insights into PCI of complex bifurcation lesions.